Because quantitative cancer risk assessment has been woven into the fabric ofgovernment regulatory processes, one might expect to find its methods carved into bureaucratic stone. The papers on cancer risk modeling at this symposium attest that this is not the case; indeed, quantitative cancer risk assessment remains a dynamic area of research. Risk analysts with varied academic backgrounds continue to improve or replace models that sometimes stem back to the 1950s. Risk assessment is probably more closely coupled now to rapidly advancing biomedical research than it has ever been before.
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First, early cancer risk assessment models focused almost entirely on models of cancer initiation, e.g., the one-hit model. There is a growing trend to expand assessment models to a more complete picture of the total process, including exposure, metabolic activation, pharnacokinetics, biologically effective dose, initiation, cellular proliferation, promotion, immunocontrol, suppression, and progression. In some cases, models of individual processes are linked together for assessment, while in others several processes are incorporated in a single model. Although it may not seem so at first, a trend toward more detailed biologically based models is not inconsistent with the simpler "model free" approach proposed by Krewski's paper (9) at this symposium. If sufficient data are not available to model adequately the full process, it may be better to use an extremely simple approach to make preliminary estimates, rather than to apply a sophisticated model to a rudimentary data set.
Third, there is a movement from reliance on upper-bound estimates to best estimates, with a more complete treatment of uncertainty and appropriate propagation ofuncertainty through the different stages of analysis. Reliance on upper-bound estimates alone can distort perceptions ofrisk, leading unknowingly to excessively conservative actions. Aspects ofuncertainty were discussed in several papers at this symposium. Mazumdar (JO), in particular, presented investigations of joint confidence region calculations and of robustness in the multistage model that illustrate this increasing focus on understanding uncertainty in the estimates.
Fourth, dtere is increasing consideration ofvariation in cancer susceptibility within the exposed population. Louis (11) , Perera (12) , and Rockette (13) 
